Théa and Coave Therapeutics sign an exclusive licensing agreement

©Eveon

Théa Open Innovation announces its partnership with Coave Therapeutics, a biotech specializing in the development of gene therapies, as part of a fundraising of 21 million euros.

This operation will allow Théa Open Innovation to enter the field of gene therapy.

Share this article